0001104659-24-030222.txt : 20240304
0001104659-24-030222.hdr.sgml : 20240304
20240304062857
ACCESSION NUMBER: 0001104659-24-030222
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240220
FILED AS OF DATE: 20240304
DATE AS OF CHANGE: 20240304
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kim Richard J
CENTRAL INDEX KEY: 0001705154
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37977
FILM NUMBER: 24712785
MAIL ADDRESS:
STREET 1: 16 FAIRWAY DRIVE
CITY: WEST WINDSOR
STATE: NJ
ZIP: 08550
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AVADEL PHARMACEUTICALS PLC
CENTRAL INDEX KEY: 0001012477
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK
STREET 2: BALLYCOOLIN
CITY: DUBLIN
STATE: L2
ZIP: 15
BUSINESS PHONE: 636-449-1830
MAIL ADDRESS:
STREET 1: 16640 CHESTERFIELD GROVE ROAD
STREET 2: SUITE 200
CITY: CHESTERFIELD
STATE: MO
ZIP: 63005
FORMER COMPANY:
FORMER CONFORMED NAME: FLAMEL TECHNOLOGIES SA
DATE OF NAME CHANGE: 19960422
4
1
tm247077-4_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-02-20
0
0001012477
AVADEL PHARMACEUTICALS PLC
AVDL
0001705154
Kim Richard J
C/O AVADEL PHARMACEUTICALS PLC
10 EARLSFORT TERRACE
DUBLIN 2
L2
D02 T380
IRELAND
0
1
0
0
Chief Commercial Officer
0
Stock Option (Right to Buy)
13.57
2024-02-20
4
A
0
147000
0.00
A
2034-02-20
ADSs
147000
147000
D
Options become exercisable as to 36,750 ADSs on each of the first four anniversaries after the 2/20/2024 grant date.
The issuer's "ADSs" are American Depositary Shares, with each ADS representing one ordinary share, nominal value $0.01 per share, of the issuer; ADSs may be represented by American Depositary Receipts.
/s/ Jerad G. Seurer, as Attorney-in-Fact
2024-03-04